文献速递神经肿瘤功能神经外科

DNA甲基化亚类受体酪氨酸激酶II(RTK II)可预测胶质母细胞瘤患者的癫痫发作

DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients.
PubMed 文献 · Neuro Oncol · 2022-01-01

该研究纳入111例接受手术的胶质母细胞瘤患者,进行全基因组DNA甲基化谱分析,并将甲基化亚类及推断的拷贝数变化与临床特征关联。结果显示RTK II亚类患者癫痫发生率显著高于RTK I和间充质(MES)亚类(P<.01),术后随访中仅RTK II与癫痫发作显著相关(P<.01,OR 8.23)。结论认为RTK II胶质母细胞瘤与术前及长期癫痫发作强相关,分子分型对术后癫痫控制有重要意义。

要点

  • RTK II胶质母细胞瘤患者癫痫发生率显著高于RTK I和间充质亚类(P<.01)。
  • 多因素分析中,颞叶位置(P=.02,OR 5.69)和RTK II(P=.03,OR 5.01)对术前癫痫预测最强。
  • 术后随访中仅RTK II与癫痫发作显著相关(P<.01,OR 8.23),且抗癫痫药物需求及因治疗失败而增加用药与RTK II高度相关(P<.01)。

核心结论

  • RTK II胶质母细胞瘤与术前及长期癫痫发作强相关,分子分型对术后癫痫控制有重要意义。

研究设计与样本

  • 纳入111例接受手术的胶质母细胞瘤患者,进行全基因组DNA甲基化谱分析,并将甲基化亚类及推断的拷贝数变化与临床特征关联。
  • 独立分析TCGA数据集中胶质母细胞瘤甲基化亚类的全局基因表达(n=68)。

主要发现

  • RTK II胶质母细胞瘤癫痫发生率显著高于RTK I和间充质(MES)胶质母细胞瘤(P<.01)。
  • RNA表达数据集显示RTK II胶质母细胞瘤中神经递质突触和囊泡运输相关基因上调。
  • 多因素分析中,颞叶位置(P=.02,OR 5.69)和RTK II(P=.03,OR 5.01)对术前癫痫预测最强。
  • 术后随访中,仅RTK II与癫痫发作显著相关(P<.01,OR 8.23)。
  • 抗癫痫药物需求及因治疗失败而增加用药与RTK II甲基化亚类高度相关(P<.01)。

临床怎么用

  • 作者认为分子分型对术后癫痫控制有重要意义,但原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Seizures can present at any time before or after the diagnosis of a glioma. Roughly, 25%-30% of glioblastoma (GBM) patients initially present with seizures, and an additional 30% develop seizures during the course of the disease. Early studies failed to show an effect of general administration of antiepileptic drugs for glioblastoma patients, since they were unable to stratify patients into high- or low-risk seizure groups. METHODS: 111 patients, who underwent surgery for a GBM, were included. Genome-wide DNA methylation profiling was performed, before methylation subclasses and copy number changes inferred from methylation data were correlated with clinical characteristics. Independently, global gene expression was analyzed in GBM methylation subclasses from TCGA datasets (n = 68). RESULTS: Receptor tyrosine Kinase (RTK) II GBM showed a significantly higher incidence of seizures than RTK I and mesenchymal (MES) GBM (P < .01). Accordingly, RNA expression datasets revealed an upregulation of genes involved in neurotransmitter synapses and vesicle transport in RTK II glioblastomas. In a multivariate analysis, temporal location (P = .02, OR 5.69) and RTK II (P = .03, OR 5.01) were most predictive for preoperative seizures. During postoperative follow-up, only RTK II remained significantly associated with the development of seizures (P < .01, OR 8.23). Consequently, the need for antiepileptic medication and its increase due to treatment failure was highly associated with the RTK II methylation subclass (P < .01). CONCLUSION: Our study shows a strong correlation of RTK II glioblastomas with preoperative and long-term seizures. These results underline the benefit of molecular glioblastoma profiling with important implications for postoperative seizure control.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Ricklefs FL, Drexler R, Wollmann K, et al. DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients. Neuro Oncol. 2022. PMID: 35511473. doi:10.1093/neuonc/noac108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。